Austevoll Seafood ASA
ISIN: NO0010073489 | Ticker: AUSS | LEI: 5967007LIEEXZXFFDC03
Country: Norway
The history of Austevoll Seafood ASA (AUSS) is strongly rooted in Austevoll, Norway. The island’s heritage, where historically fishing has been the main industry, has created a culture of competitiveness, business savvy and always hard working. Our beginning can be traced back to Austevoll Havfiske AS, a company established in 1981 by Helge Møgster, Ole Rasmus Møgster and their father. Over the last decade, AUSS has acquired a significant number of companies of a complementary nature to its existing business areas.
Today, AUSS includes the ownership and operation of fishing vessels (both pelagic and white fish), fishmeal plants, canning plants, freezing plants, salmon farming, and marketing and sales. The Group has its main locations in Norway, UK, Peru and Chile.
1981
Served areaWorldwide
HeadquartersAlfabygget, 5392 Storebø – Norway
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 39,741,000,000.00 | 43,781,000,000.00 | 48,062,000,000.00 |
| Noncurrent Assets | N/A | 25,743,000,000.00 | 27,310,000,000.00 | 29,134,000,000.00 |
| Ships | N/A | 2,103,000,000.00 | 2,385,000,000.00 | 2,628,000,000.00 |
| Other Property Plant And Equipment | N/A | 6,275,000,000.00 | 6,896,000,000.00 | 7,629,000,000.00 |
| Goodwill | N/A | 1,958,000,000.00 | 2,217,000,000.00 | 2,279,000,000.00 |
| Brand Names | N/A | 50,000,000.00 | 50,000,000.00 | 50,000,000.00 |
| Licences And Franchises | N/A | 9,460,000,000.00 | 9,412,000,000.00 | 9,518,000,000.00 |
| Investment Accounted For Using Equity Method | N/A | 2,527,000,000.00 | 3,002,000,000.00 | 3,382,000,000.00 |
| Deferred Tax Assets | N/A | 58,000,000.00 | 69,000,000.00 | 160,000,000.00 |
| Other Noncurrent Assets | N/A | 164,000,000.00 | 168,000,000.00 | 223,000,000.00 |
| Current Assets | N/A | 13,998,000,000.00 | 16,471,000,000.00 | 18,928,000,000.00 |
| Current Trade Receivables | N/A | 2,045,000,000.00 | 2,321,000,000.00 | 2,909,000,000.00 |
| Current Biological Assets | N/A | 5,166,000,000.00 | 6,173,000,000.00 | 7,972,000,000.00 |
| Cash and cash equivalents | 4,251,000,000.00 | 4,463,000,000.00 | 5,329,000,000.00 | 4,340,000,000.00 |
| Balances With Banks | N/A | 4,463,000,000.00 | 5,329,000,000.00 | 4,340,000,000.00 |
| Other Current Assets | N/A | 754,000,000.00 | 717,000,000.00 | 751,000,000.00 |
| Equity And Liabilities | N/A | 39,741,000,000.00 | 43,781,000,000.00 | 48,062,000,000.00 |
| Equity | 23,332,000,000.00 | 22,991,000,000.00 | 25,187,000,000.00 | 28,162,000,000.00 |
| Issued Capital | N/A | 101,000,000.00 | 101,000,000.00 | 101,000,000.00 |
| Share Premium | N/A | 3,714,000,000.00 | 3,714,000,000.00 | 3,714,000,000.00 |
| Treasury Shares | N/A | 18,000,000.00 | 18,000,000.00 | 18,000,000.00 |
| Noncontrolling Interests | N/A | 10,882,000,000.00 | 11,815,000,000.00 | 12,841,000,000.00 |
| Liabilities | N/A | 16,750,000,000.00 | 18,594,000,000.00 | 19,900,000,000.00 |
| Noncurrent Liabilities | N/A | 11,130,000,000.00 | 12,623,000,000.00 | 12,021,000,000.00 |
| Noncurrent Provisions | N/A | 43,000,000.00 | 11,000,000.00 | 13,000,000.00 |
| Deferred Tax Liabilities | N/A | 3,261,000,000.00 | 3,512,000,000.00 | 3,581,000,000.00 |
| Other Noncurrent Liabilities | N/A | 26,000,000.00 | 30,000,000.00 | 30,000,000.00 |
| Longterm Borrowings | N/A | 5,651,000,000.00 | 6,663,000,000.00 | 5,968,000,000.00 |
| Current Liabilities | N/A | 5,620,000,000.00 | 5,971,000,000.00 | 7,879,000,000.00 |
| Current Tax Liabilities Current | N/A | 405,000,000.00 | 686,000,000.00 | 1,023,000,000.00 |
| Other Current Liabilities | N/A | 1,267,000,000.00 | 1,507,000,000.00 | 1,543,000,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 2,072,000,000.00 | 1,315,000,000.00 | 2,263,000,000.00 |
| Line item in (nok) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue From Contracts With Customers | 22,435,000,000.00 | 26,571,000,000.00 | 31,169,000,000.00 |
| Raw Materials And Consumables Used | 13,079,000,000.00 | 14,109,000,000.00 | 16,294,000,000.00 |
| Employee Benefits Expense | 3,605,000,000.00 | 4,064,000,000.00 | 4,519,000,000.00 |
| Depreciation Expense | 929,000,000.00 | 968,000,000.00 | 1,038,000,000.00 |
| Amortisation Expense | 48,000,000.00 | 45,000,000.00 | 81,000,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | -3,000,000.00 | 13,000,000.00 | -1,000,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | -3,000,000.00 | 13,000,000.00 | -1,000,000.00 |
| Other Gains Losses | 11,000,000.00 | 62,000,000.00 | -20,000,000.00 |
| Profit Loss From Operating Activities | 1,205,000,000.00 | 4,332,000,000.00 | 5,240,000,000.00 |
| Finance Income | 290,000,000.00 | 394,000,000.00 | 848,000,000.00 |
| Finance Costs | 717,000,000.00 | 744,000,000.00 | 1,155,000,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 250,000,000.00 | 394,000,000.00 | 494,000,000.00 |
| Profit Loss Before Tax | 1,027,000,000.00 | 4,376,000,000.00 | 5,428,000,000.00 |
| Income Tax Expense Continuing Operations | 205,000,000.00 | 939,000,000.00 | 1,142,000,000.00 |
| Profit (loss) | 823,000,000.00 | 3,437,000,000.00 | 4,285,000,000.00 |
| Profit Loss Attributable To Owners Of Parent | 494,000,000.00 | 1,982,000,000.00 | 2,490,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 329,000,000.00 | 1,455,000,000.00 | 1,795,000,000.00 |
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 823,000,000.00 | 3,437,000,000.00 | 4,285,000,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | N/A | -335,000,000.00 | 443,000,000.00 | 459,000,000.00 |
| Adjustments For Increase Decrease In Other Operating Payables | N/A | 15,000,000.00 | 102,000,000.00 | -22,000,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 1,519,000,000.00 | 1,580,000,000.00 | 1,732,000,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | -3,000,000.00 | 13,000,000.00 | -1,000,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | 58,000,000.00 | -45,000,000.00 | -32,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | -491,000,000.00 | -447,000,000.00 | -775,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 2,944,000,000.00 | 4,635,000,000.00 | 3,195,000,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 17,000,000.00 | 43,000,000.00 | 54,000,000.00 |
| Interest Received Classified As Investing Activities | N/A | 46,000,000.00 | 39,000,000.00 | 79,000,000.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | N/A | -28,000,000.00 | -4,000,000.00 | -55,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -1,403,000,000.00 | -1,650,000,000.00 | -1,675,000,000.00 |
| Dividends Paid Classified As Financing Activities | N/A | 507,000,000.00 | 706,000,000.00 | 908,000,000.00 |
| Interest Paid Classified As Financing Activities | N/A | 345,000,000.00 | 326,000,000.00 | 441,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -1,326,000,000.00 | -2,128,000,000.00 | -2,547,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -3,000,000.00 | 9,000,000.00 | 38,000,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 215,000,000.00 | 856,000,000.00 | -1,027,000,000.00 |
| Cash and cash equivalents | 4,251,000,000.00 | 4,463,000,000.00 | 5,329,000,000.00 | 4,340,000,000.00 |
Please note that some sums might not add up.
NO0010073489
LEI5967007LIEEXZXFFDC03
SectorAgricultural Products & Services
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.